Home
Conditions
Hepatocellular Carcinoma

Clinical trial condition

Hepatocellular Carcinoma

Explore clinical trials studying Hepatocellular Carcinoma. Study availability and eligibility vary by location and protocol.

1,013 public trials 264 recruiting studies

Refine in advanced search Browse all conditions

Hepatocellular Carcinoma trial results

Not Yet Recruiting

Study on the Safety and Efficacy of BST06 Injection in the Treatment of Advanced Hepatocellular Carcinoma

NCT06645314

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Anti-cancer Potentiality of Saffron Against Hepatocellular Carcinoma

NCT06464380

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Amal A. Elkholy Al ‘Abbāsīyah, Al Abbasiya, Egypt

Dermatology Clinic of National Hepatology and Tropical Medicine Research Institute Cairo, Egypt

View Trial Details

Not Yet Recruiting

Second-line Systemic Therapy Combined with SBRT for HCC with Oligoprogression After Standard First-line Systemic Treatment

NCT06592612

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study of Camrelizumab Plus Apatinib as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Radical Resection or Ablation

NCT06546280

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Zhujiang Hospital of Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Transfemoral Versus Transradial Approach in Transarterial Chemoembolization of Hepatocellular Carcinoma

NCT06543030

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Assiut University hospitals Asyut, Egypt

View Trial Details

Not Yet Recruiting

SBRT Combined With Adbelimumab and Apatinib for Perioperative and Conversion Therapy of Hepatocellular Carcinoma

NCT06538935

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Donafenib Combine With Sintilimab and HAIC in Neoadjuvant of Resectable Hepatocellular Carcinoma

NCT06512467

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

HAIC Combined With TQB2450 and Anlotinib in Second-line Treatment of Advanced Hepatocellular Carcinoma

NCT06475287

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Postoperative Adjuvant Sintilimab in Hepatocellular Carcinoma With Microvascular Invasion

NCT06089369

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Not Yet Recruiting

Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial of Hepatocellular Carcinoma Resistant to PD-1 Monoclonal Antibody

NCT06364800

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details

Hepatocellular Carcinoma

Hepatocellular Carcinoma trial results

Related conditions